129 related articles for article (PubMed ID: 6672502)
1. The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage.
Dooley JS; Gooding A; Hamilton-Miller JM; Brumfitt W; Sherlock S
Liver; 1983 Aug; 3(4):201-6. PubMed ID: 6672502
[TBL] [Abstract][Full Text] [Related]
2. Biliary excretion of mezlocillin in patients with hepatic disease.
Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
[TBL] [Abstract][Full Text] [Related]
3. The biliary excretion of sulphated and non-sulphated bile acids and bilirubin in patients with external bile drainage.
Dooley JS; Bartholomew C; Summerfield JA; Billing BH
Clin Sci (Lond); 1984 Jul; 67(1):61-8. PubMed ID: 6734078
[TBL] [Abstract][Full Text] [Related]
4. [Biliary excretion of mezlocillin].
Rösch W; Stock KP; Burkhardt F
Fortschr Med; 1981 Jan; 99(3):76-8. PubMed ID: 6451569
[TBL] [Abstract][Full Text] [Related]
5. [Bile composition and antibiotic excretion. Observations with T-drainage].
Rosenthal RJ; Steigerwald SD; Bockhorn H
Z Gesamte Inn Med; 1993 Jan; 48(1):18-22. PubMed ID: 8095119
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of mezlocillin in patients with biliary t-tube drainage.
Gundert-Remy U; Förster D; Schacht P; Weber E
J Antimicrob Chemother; 1982 Jan; 9 Suppl A():65-75. PubMed ID: 6210684
[No Abstract] [Full Text] [Related]
7. [Clinical studies on the biliary excretion of mezlocillin, especially in cases with liver dysfunction].
Maeba T; Hashimoto T; Takeda T; Shiraishi Y; Oike H; Wakabayashi H; Omori G; Indo S; Kunikata E; Hayashi M
Jpn J Antibiot; 1986 Jan; 39(1):116-20. PubMed ID: 3702053
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of biliary tract infections (XXIV). Biliary excretion and gallbladder tissue levels of mezlocillin].
Kobayashi N; Tanimura H; Huang WF; Sekiya T; Takahashi H; Sato T; Yoshida K; Hikasa Y
Jpn J Antibiot; 1984 Apr; 37(4):597-604. PubMed ID: 6471380
[TBL] [Abstract][Full Text] [Related]
9. Bile acid synthesis and excretion following release of total extrahepatic cholestasis by percutaneous transhepatic drainage.
Eklund A; Norlander A; Norman A
Eur J Clin Invest; 1980 Oct; 10(5):349-55. PubMed ID: 6777167
[TBL] [Abstract][Full Text] [Related]
10. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime.
Leung JW; Chan RC; Cheung SW; Sung JY; Chung SC; French GL
J Antimicrob Chemother; 1990 Mar; 25(3):399-406. PubMed ID: 2187012
[TBL] [Abstract][Full Text] [Related]
11. [Comparative biliary excretion of mezlocillin and 12 other beta-lactam antibiotics (author's transl)].
Comte F; Brogard JM; Kopferschmitt J; Dorner M; Lavillaureix J
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):353-60. PubMed ID: 6460975
[TBL] [Abstract][Full Text] [Related]
12. Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction.
Levi JU; Martinez OV; Malinin TI; Zeppa R; Livingstone A; Hutson D; Calhoun P
Antimicrob Agents Chemother; 1984 Dec; 26(6):944-6. PubMed ID: 6524908
[TBL] [Abstract][Full Text] [Related]
13. Nonlinear mezlocillin kinetics due to dose-dependent metabolism.
Gundert-Remy U; Hildebrandt R; Stiehl A; Weber E
Clin Pharmacol Ther; 1983 May; 33(5):656-62. PubMed ID: 6220858
[TBL] [Abstract][Full Text] [Related]
14. Differences in biliary lipid excretion after major hepatectomy in obstructive jaundiced rats with preoperative internal, external, or no biliary drainage.
Mizuta A; Chijiiwa K; Saiki S; Kuroki S; Nakamura K; Tanaka M
Eur Surg Res; 2002; 34(4):291-9. PubMed ID: 12145555
[TBL] [Abstract][Full Text] [Related]
15. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice.
Chijiiwa K; Watanabe M; Nakano K; Noshiro H; Tanaka M
Am J Surg; 2000 Feb; 179(2):161-6. PubMed ID: 10773154
[TBL] [Abstract][Full Text] [Related]
16. Effect of ursodeoxycholate on the biliary excretion of cefotiam and sulbenicillin in patients with percutaneous transhepatic biliary drainage.
Higashi K; Hayakawa T; Katagiri K; Tsukada K; Ito K; Hoshino M; Miyaji M; Takeuchi T; Yamamoto T
Antimicrob Agents Chemother; 1988 May; 32(5):726-9. PubMed ID: 3164988
[TBL] [Abstract][Full Text] [Related]
17. Diurnal variation in the biliary excretion of flomoxef in patients with percutaneous transhepatic biliary drainage.
Hishikawa S; Kobayashi E; Sugimoto K; Miyata M; Fujimura A
Br J Clin Pharmacol; 2001 Jul; 52(1):65-8. PubMed ID: 11453891
[TBL] [Abstract][Full Text] [Related]
18. The effect of biliary decompression on antibiotic biliary excretion.
Yamamoto S; Kubota Y; Takaoka M; Ogura M; Tsuji K; Yanagitani K; Shimatani M; Shibatani N; Imai Y; Takamidoh S; Inoue K
Hepatogastroenterology; 2002; 49(44):330-4. PubMed ID: 11995444
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction.
Meyers BR; Srulevitch ES; Sacks HS; Hirschman SZ; Worner TM; Wormser GP; Jacobson J
J Antimicrob Chemother; 1986 Dec; 18(6):709-13. PubMed ID: 3818496
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of refractory malignant biliary obstraction: comparing results of percutaneous transhepatic biliary drainage with external catheters or endoscopic metallic stenting].
Zou XP; Zhan XB; Li ZS; Jin ZD; Wan XJ; Wang N; Xu GM
Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):109-11. PubMed ID: 15059407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
